245 related articles for article (PubMed ID: 31590648)
1. Risk factors and survival of patients infected with carbapenem-resistant Klebsiella pneumoniae in a KPC endemic setting: a case-control and cohort study.
Cienfuegos-Gallet AV; Ocampo de Los Ríos AM; Sierra Viana P; Ramirez Brinez F; Restrepo Castro C; Roncancio Villamil G; Del Corral Londoño H; Jiménez JN
BMC Infect Dis; 2019 Oct; 19(1):830. PubMed ID: 31590648
[TBL] [Abstract][Full Text] [Related]
2. Healthcare-associated carbapenem-resistant Klebsiella pneumoniae infections are associated with higher mortality compared to carbapenem-susceptible K. pneumoniae infections in the intensive care unit: a retrospective cohort study.
Yao Y; Zha Z; Li L; Tan H; Pi J; You C; Liu B
J Hosp Infect; 2024 Jun; 148():30-38. PubMed ID: 38513959
[TBL] [Abstract][Full Text] [Related]
3. Risk Factors for Carbapenem-resistant
Wang Z; Qin RR; Huang L; Sun LY
Chin Med J (Engl); 2018 Jan; 131(1):56-62. PubMed ID: 29271381
[TBL] [Abstract][Full Text] [Related]
4. Clinical and Molecular Characterizations of Carbapenem-Resistant Klebsiella pneumoniae Causing Bloodstream Infection in a Chinese Hospital.
Zhang N; Qi L; Liu X; Jin M; Jin Y; Yang X; Chen J; Qin S; Liu F; Tang Y; Jia R; Zhang X; Wang Y; Guo J; Liu J; Wang C; Chen Y
Microbiol Spectr; 2022 Oct; 10(5):e0169022. PubMed ID: 36190403
[TBL] [Abstract][Full Text] [Related]
5. Healthcare-associated carbapenem-resistant Klebsiella pneumoniae bloodstream infections: Risk factors, mortality, and antimicrobial susceptibility, 2017-2019.
Hsu JY; Chuang YC; Wang JT; Chen YC; Hsieh SM
J Formos Med Assoc; 2021 Nov; 120(11):1994-2002. PubMed ID: 33962811
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for bacteriuria with carbapenem-resistant Klebsiella pneumoniae and its impact on mortality: a case-control study.
Shilo S; Assous MV; Lachish T; Kopuit P; Bdolah-Abram T; Yinnon AM; Wiener-Well Y
Infection; 2013 Apr; 41(2):503-9. PubMed ID: 23271210
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for infection with carbapenem-resistant Klebsiella pneumoniae: a case-case-control study.
Gómez Rueda V; Zuleta Tobón JJ
Colomb Med (Cali); 2014; 45(2):54-60. PubMed ID: 25100889
[TBL] [Abstract][Full Text] [Related]
8. Impact of carbapenem resistance on the outcome of patients' hospital-acquired bacteraemia caused by Klebsiella pneumoniae.
Hussein K; Raz-Pasteur A; Finkelstein R; Neuberger A; Shachor-Meyouhas Y; Oren I; Kassis I
J Hosp Infect; 2013 Apr; 83(4):307-13. PubMed ID: 23313086
[TBL] [Abstract][Full Text] [Related]
9. Multicenter Genomic Analysis of Carbapenem-Resistant Klebsiella pneumoniae from Bacteremia in China.
Cienfuegos-Gallet AV; Zhou Y; Ai W; Kreiswirth BN; Yu F; Chen L
Microbiol Spectr; 2022 Apr; 10(2):e0229021. PubMed ID: 35230130
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for carbapenem-resistant K. pneumoniae bloodstream infection and predictors of mortality in Chinese paediatric patients.
Zhang Y; Guo LY; Song WQ; Wang Y; Dong F; Liu G
BMC Infect Dis; 2018 May; 18(1):248. PubMed ID: 29855274
[TBL] [Abstract][Full Text] [Related]
11. [Klebsiella pneumoniae Infections in the Intensive Care Unit: Risk Factors Related to Carbapenem Resistance and Patient Mortality].
Büyüktuna SA; Hasbek M; Çelik C; Ünlüsavuran M; Avcı O; Baltacı S; Fırtına Topcu K; Elaldı N
Mikrobiyol Bul; 2020 Jul; 54(3):378-391. PubMed ID: 32755515
[TBL] [Abstract][Full Text] [Related]
12. In-Human Multiyear Evolution of Carbapenem-Resistant Klebsiella pneumoniae Causing Chronic Colonization and Intermittent Urinary Tract Infections: A Case Study.
Kalu M; Tan K; Algorri M; Jorth P; Wong-Beringer A
mSphere; 2022 Jun; 7(3):e0019022. PubMed ID: 35531657
[TBL] [Abstract][Full Text] [Related]
13. Attributable mortality of carbapenem-resistant Klebsiella pneumoniae infections in a prospective matched cohort study in Italy, 2012-2013.
Hoxha A; Kärki T; Giambi C; Montano C; Sisto A; Bella A; D'Ancona F;
J Hosp Infect; 2016 Jan; 92(1):61-6. PubMed ID: 26319590
[TBL] [Abstract][Full Text] [Related]
14. Risk factors and mortality for patients with Bloodstream infections of Klebsiella pneumoniae during 2014-2018: Clinical impact of carbapenem resistance in a large tertiary hospital of China.
Chang H; Wei J; Zhou W; Yan X; Cao X; Zuo L; Chen S; Yao K; Huang R; Chen Y; Wu C
J Infect Public Health; 2020 May; 13(5):784-790. PubMed ID: 31843651
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for infection and mortality caused by carbapenem-resistant Klebsiella pneumoniae: A large multicentre case-control and cohort study.
Lou T; Du X; Zhang P; Shi Q; Han X; Lan P; Yan R; Hu H; Wang Y; Wu X; Jiang Y; Yu Y
J Infect; 2022 May; 84(5):637-647. PubMed ID: 35301013
[TBL] [Abstract][Full Text] [Related]
16. Molecular Epidemiology and Risk Factors of Carbapenem-Resistant Klebsiella Pneumoniae Bloodstream Infections in Wuhan, China.
Liu C; Liu L; Jin MM; Hu YB; Cai X; Wan L; Zhang HY; Li RY; Wu XJ
Curr Med Sci; 2022 Feb; 42(1):68-76. PubMed ID: 34985611
[TBL] [Abstract][Full Text] [Related]
17. Enhancing resistance, but not virulence attributed to the high mortality caused by carbapenem-resistant Klebsiella pneumoniae.
Yang C; Xu Q; Xie M; Tang Y; Hu Q; Heng H; Yang X; Liu X; Chan EW; Yang G; Chen S
Microbiol Res; 2024 Aug; 285():127769. PubMed ID: 38797112
[TBL] [Abstract][Full Text] [Related]
18. Carbapenem Resistance, Initial Antibiotic Therapy, and Mortality in Klebsiella pneumoniae Bacteremia: A Systematic Review and Meta-Analysis.
Kohler PP; Volling C; Green K; Uleryk EM; Shah PS; McGeer A
Infect Control Hosp Epidemiol; 2017 Nov; 38(11):1319-1328. PubMed ID: 28950924
[TBL] [Abstract][Full Text] [Related]
19. Carbapenem-resistant Klebsiella pneumoniae infections in kidney transplant recipients: a case-control study.
Simkins J; Muggia V; Cohen HW; Minamoto GY
Transpl Infect Dis; 2014 Oct; 16(5):775-82. PubMed ID: 25092500
[TBL] [Abstract][Full Text] [Related]
20. Mortality-related factors in patients with OXA-48 carbapenemase-producing Klebsiella pneumoniae bacteremia.
Rodríguez OL; Sousa A; Pérez-Rodríguez MT; Martínez-Lamas L; Suárez RL; Martínez CT; Pino CP; Vidal FV; Pérez-Landeiro A; Casal MC
Medicine (Baltimore); 2021 Apr; 100(14):e24880. PubMed ID: 33832068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
